Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.52M Sell
156,419
-138,872
-47% -$6.1M 0.18% 82
2025
Q4
$14.5M Sell
295,291
-47,100
-14% -$1.98M 0.46% 59
2025
Q3
$16.5M Sell
342,391
-529,855
-61% -$20M 0.49% 50
2025
Q2
$26.6M Sell
872,246
-84,593
-9% -$2.27M 0.91% 34
2025
Q1
$25.5M Buy
956,839
+49,800
+5% +$1.49M 0.89% 40
2024
Q4
$30.4M Buy
907,039
+467,401
+106% +$20.7M 0.9% 41
2024
Q3
$19.8M Buy
439,638
+142,450
+48% +$4.82M 0.56% 49
2024
Q2
$6.21M Buy
297,188
+171,221
+136% +$2.56M 0.19% 66
2024
Q1
$1.67M Sell
125,967
-1,372,617
-92% -$14.6M 0.05% 70
2023
Q4
$16.8M Sell
1,498,584
-310,100
-17% -$3.67M 0.62% 47
2023
Q3
$26M Buy
1,808,684
+356,146
+25% +$6.23M 0.82% 44
2023
Q2
$27.7M Hold
1,452,538
0.9% 41
2023
Q1
$30.7M Buy
+1,452,538
New +$24.8M 1.01% 37

Other funds holding HROW

Braidwell's HROW Position: Q1 2026 in Review

Braidwell reduced its Harrow (HROW) stake by 47% in Q1 2026, selling an estimated $6.1M and leaving 156,419 shares worth $5.52M. The position accounts for 0.18% of the portfolio, ranked #82.

Braidwell first reported a position in HROW in Q1 2023 and has held it in 13 quarters since. The position peaked at $30.7M in Q1 2023. 218 funds tracked by Wall St. Rank hold HROW as of Q1 2026.

  • Braidwell held 156,419 shares of Harrow worth $5.52M as of Q1 2026.
  • Braidwell sold 138,872 Harrow shares in Q1 2026, an estimated $6.1M.
  • Harrow made up 0.18% of Braidwell's portfolio in Q1 2026, its #82 holding.
  • Braidwell first reported a position in Harrow in Q1 2023 and has held it in 13 quarters since.
  • Braidwell's Harrow position peaked at $30.7M in Q1 2023.
  • 218 funds tracked by Wall St. Rank held Harrow as of Q1 2026.

Based on Braidwell's 13F filing for Q1 2026, filed 15 May 2026.